Sage Journals: Discover world-class research

Abstract

Accessory mitral valve tissue is a rare congenital cardiac anomaly that can lead to left ventricular outflow tract obstruction. We present the case of an older female patient with accessory mitral valve tissue, a subaortic membrane, an unruptured aneurysm of the aortic sinus, and left ventricular outflow tract obstruction. Successful excision of the accessory mitral valve tissue and repair of the aortic sinus were performed. Postoperative echocardiography showed complete removal of the subaortic membrane, with a residual accessory mitral valve tissue (5 mm). Color Doppler imaging revealed a significant reduction in mosaic flow signals in the left ventricular outflow tract, with the peak blood flow velocity decreasing to 1.6 m/s. The postoperative course was uneventful, and the patient was followed up with echocardiography at 3 days, 5 days, 1 month, 3 months, and 6 months after the surgery. Accessory mitral valve tissue is a rare congenital defect frequently associated with other cardiovascular congenital malformations. This report also provides a comprehensive clinical review of accessory mitral valve tissue, covering anatomical classification, associated cardiac anomalies, pathophysiology, diagnostic approaches, and treatment strategies to offer an improved clinical understanding of the condition.

Keywords

Accessory mitral valve tissue left ventricular outflow tract obstruction echocardiography subaortic membrane cardiac malformation case report

Introduction

Accessory mitral valve tissue (AMVT) is an additional valvular structure attached to the normal mitral valve apparatus within the left-sided cardiac chambers. It is a rare congenital anomaly that was first described in 1842; the first surgical intervention was reported in 1963.¹ AMVT results from incomplete separation of the mitral valve from the endocardial cushion tissue during embryonic development.² Typically originating from the anterior mitral leaflet, AMVT protrudes into the left ventricular outflow tract (LVOT), potentially causing LVOT obstruction. It is frequently associated with other congenital cardiovascular malformations. Here, we present the case of an elderly female patient diagnosed with AMVT, LVOT obstruction, a subaortic membrane, and an unruptured aneurysm of the aortic sinus.

Timeline

1 May 2024: The patient was referred to the Department of Emergency

1 and 16 May 2024: Transthoracic echocardiography (TTE) was performed

17 May 2024: Surgical treatment was carried out (The operation time was 09:30–13:10). Pre-operative and postoperative transesophageal echocardiography (TEE) were performed to evaluate surgical curative effects.

20 May 2024: The first TTE was performed after the operation.

22 May 2024: The second TTE was performed after the operation.

26 May 2024: The patient was discharged from our hospital.

Case presentation

A female patient in her early 60s was referred to the Emergency Department of Mianyang Central Hospital on 1 May 2024 due to exertional shortness of breath that had persisted for 1 month. Her symptoms had worsened over the past week, leading to increasing dyspnea, orthopnea, and atypical chest pain, which hindered her daily activities.

An electrocardiogram showed third-degree atrioventricular block. The patient, with an 8-year history of hypertension, had elevated blood pressure (164/69 mmHg) and a grade 3/6 systolic murmur along the left sternal border. Chest auscultation revealed normal breath sounds. No peripheral edema or jugular venous distention was observed. Laboratory tests showed leukocytosis with a white blood cell count of 11.12 × 10⁹ cells/L (normal value: 3.5–9.5 × 10⁹ cells/L) as well as elevated levels of procalcitonin (2.59 µg/L; normal value: 0–0.046 µg/L), C-reactive protein (28.73 mg/L; normal value: 1–10 mg/L), and N-terminal pro-B-type natriuretic peptide (1909 ng/L; normal value: <125 ng/L).

TTE revealed a parachute-like anomaly arising from the left ventricular side of the anterior mitral leaflet, protruding into the LVOT during systole. The parasternal long-axis view showed the relationship between the normal mitral valve and the abnormal structure (Figure 1). The peak blood flow velocity across the LVOT was elevated at 3.0 m/s, with a corresponding peak gradient of 36 mmHg (Figure 2). A fixed, membrane-like structure was also observed, which was attached to the basal portion of the interventricular septum. Additionally, an unruptured aneurysm of the aortic sinus was identified, measuring 16 mm × 6 mm (Figure 3). Further TTE findings included mild-to-moderate mitral regurgitation, mild aortic regurgitation, and mild dilation of the left atrium (3.9 cm) and left ventricle (end-diastolic diameter = 5.1 cm). Left ventricular systolic function was preserved, with an ejection fraction of 63%. The dimensions and morphology of the aorta were normal. Based on these finding, a diagnosis of AMVT associated with a subaortic membrane and an unruptured aneurysm of the aortic sinus was established.

Figure 1.

The parasternal long-axis view revealing a fixed accessory mitral valve tissue attached to the anterior mitral leaflet causing left ventricular outflow tract obstruction.

Figure 2.

Apical five-chamber view: continuous-wave Doppler examination showing a peak blood flow velocity across left ventricular outflow tract of 3.0 m/s.

Figure 3.

The short-axis view revealing an unruptured aneurysm of the aortic sinus measuring 16 mm × 6 mm.

Following a comprehensive clinical evaluation, surgical intervention was deemed necessary due to the presence of LVOT obstruction and the patient’s progressively worsening symptoms. The patient consented to the procedure and signed the informed consent form. Intraoperative findings were consistent with the TTE imaging diagnosis. Resection of the AMVT and subaortic membrane along with repair of the aortic sinus were successfully performed. Immediate postoperative TEE confirmed complete excision of the subaortic membrane, with a residual AMVT measuring 5 mm. Color Doppler imaging showed a marked reduction in mosaic flow signals in the LVOT, with peak blood flow velocity decreasing to 1.6 m/s. Histological examination revealed accessory valvular tissue with mucoid degeneration and inflammatory cell infiltration. The membranous structure demonstrated proliferation of fibrous connective tissue (Figures 4 and 5).

Figure 4.

Low-magnification histological examination revealing accessory valvular tissue with mucoid degeneration and inflammatory cell infiltration.

Figure 5.

High-magnification histological examination revealing accessory valvular tissue characterized by mucoid degeneration and inflammatory cell infiltration.

The postoperative course was uneventful. Upon discharge, the patient was prescribed a long-term regimen of furosemide (20 mg), spironolactone (20 mg), and rivaroxaban (15 mg) each to be taken orally once daily. Follow-up echocardiography was conducted at 3 days, 5 days, 1 month, 3 months, and 6 months after the surgery. At the final follow-up, the patient reported complete resolution of shortness of breath and no recurrence of chest pain. This case report adheres to the Case Report (CARE) guidelines.³

Discussion

Epidemiological data

AMVT is a rare congenital cardiovascular malformation. Its embryological origin remains unclear; however, it is believed to be related to abnormal or incomplete separation of the mitral valve from the endocardial cushions.^4,5 Although the exact prevalence of AMVT is unclear, some studies estimate it to occur in approximately 1 in 26,000 adults.^6,7 AMVT is more commonly identified in males, with a reported male-to-female ratio of 1.75:1.⁸ Historically, AMVT was considered a cardiac anomaly predominantly affecting children. However, increasing evidence has shown that it can also be diagnosed in adults and older adults, with reported in patients aged 6 days to 96 years.^9–12 AMVT can present in various morphological forms, including membrane-like, flap-like, sheet-like, balloon-like, string-like structures, parachute-like masses, nodular gelatinous masses, structures, and pedunculated structures. These descriptive terms reflect the wide range of its anatomical appearances.¹³ Histopathological examination of typically reveals mucoid degeneration and infiltration by inflammatory cells.¹⁴

Anatomical classification

Currently, two primary classification systems are used to categorize AMVT. Prifti et al. classified AMVT based on morphological characteristics into fixed type (Type I) and mobile type (Type II) forms. Type I is further divided into nodular (Type IA) and membranous (Type IB) subtypes. Type II is subdivided into pedunculated (Type IIA) and membrane-like (Type IIB) forms. Type IIB can be further classified based on chordal development as follows: rudimentary chordae tendineae (Type IIB1) and well-developed chordae tendineae (Type IIB2).¹⁵ An alternative classification proposed by Yetkin et al. is based on the anatomical relationship of the AMVT to the mitral valve.¹³ In this system, Type I refers to tissue located above the mitral valve, Type II to the tissue on the mitral valve, and Type III to the tissue below the mitral valve.

Cardiac malformations and pathophysiology

AMVT is frequently associated with various congenital cardiovascular anomalies, including ventricular septal defect (VSD), subaortic membrane, atrial septal defect, patent ductus arteriosus, mitral cleft, transposition of the great arteries, aortic coarctation, Ebstein’s anomaly, coronary artery malformations, and double-outlet right ventricle.^7,11,13 Li et al. reported a case of AMVT coexisting with a parachute-like mitral valve, VSD, bicuspid aortic valve, and aortic sinus aneurysm.¹⁶

From a pathophysiological standpoint, AMVT is recognized as a potential cause of LVOT obstruction. The following two primary mechanisms contribute to this obstruction: (1) the mass effect of the accessory tissue itself and (2) progressive fibrous tissue deposition caused by turbulent blood flow induced by the AMVT.^17–19 Notably, AMVT may cause latent LVOT obstruction, making stress echocardiography essential in patients presenting with exertional dyspnea or exercise-induced syncope.¹⁴ When AMVT coexists with a VSD, the peak LVOT velocity and pressure gradients may be underestimated. This underestimation arises from the following two factors: (a) part of the AMVT may protrude into the VSD during systole, reducing the degree of LVOT obstruction; (b) the VSD may serve as an alternative outflow tract, resulting in lower left ventricular pressure.²⁰

Mitral valve function is usually preserved in AMVT; however, mild mitral regurgitation can occur. In Yetkin’s classification, Type I AMVT patients often have distorted or tethered mitral valves from the accessory tissue, leading to significant mitral regurgitation, atrial enlargement, and progression to atrial fibrillation. The latter further worsens mitral regurgitation and leaflet coaptation, ultimately leading to heart failure.^13,21,22 In addition to mitral valve involvement, aortic regurgitation is not uncommon in AMVT. The aortic valve may be affected either by the Venturi effect associated with LVOT obstruction or by direct attachment of AMVT to the subaortic region of the interventricular septum or aortic cusps.²³ Finally, AMVT is considered a potential risk factor for cardiac embolism due to its mobility, fragility, and the presence of mucoid degeneration.^8,24,25

Diagnosis

The anatomical attachment sites of AMVT, its involvement in the LVOT, and associated cardiac malformations determine the clinical presentation and symptoms. Approximately one-third of patients with AMVT are asymptomatic, while others—particularly those with LVOT obstruction—may present with exertional dyspnea, fatigue, and dizziness.^12,26,27 When AMVT is associated with significant valvular regurgitation, patients may develop atrial fibrillation, congestive heart failure, or malignant arrhythmias.^28,29 AMVT is also a potential source of cardiac embolism; therefore, some individuals may experience thromboembolic events such as transient ischemic attacks^30,31 or retinal artery occlusion.^25,32

Two-dimensional TTE is the gold standard for diagnosing AMVT. It evaluates AMVT morphology and identifies various associated cardiac anomalies, such as left ventricular hypertrophy, LVOT obstruction, valvular regurgitation, and congenital malformations. Color and continuous-wave Doppler echocardiography further aid in assessing blood flow velocity across the LVOT. TEE provides a more detailed visualization of the morphology and attachment sites of AMVT. Intraoperative TEE is particularly valuable for assessing the spatial relationships among AMVT, the mitral valve, and the LVOT and for guiding complete resection while preserving mitral valve integrity. Three-dimensional echocardiography offers comprehensive imaging of the mitral valve and the surrounding structures. It is useful for determining anatomical orientation and informing surgical approaches aimed at preserving mitral valve anatomy.^33,34

Treatment

Surgical intervention is not indicated in all cases of AMVT. Treatment decisions should be based on a comprehensive clinical evaluation, considering the patient’s symptoms, presentation, and the presence of associated cardiac malformations. Currently, cardiac surgery is recommended only for patients with a significant LVOT gradient—defined as a peak gradient of ≥50 mmHg or a mean gradient of ≥25 mmHg—or for those undergoing correction of other congenital anomalies or evaluation of an intracardiac mass.¹⁷ Surgical management involves complete resection of the AMVT to relieve LVOT obstruction while carefully avoiding injury to surrounding structures, such as the mitral valve, mitral curtain, aortic valve, and the basal portion of the interventricular septum. In asymptomatic patients without associated cardiac anomalies, conservative management with routine follow-up is preferred. However, due to the risk of thromboembolic complications, antiplatelet therapy is recommended even in asymptomatic and uncomplicated cases. Additionally, lifestyle modifications, such as avoiding cigarette smoking and discontinuing oral contraceptive use, are advised to minimize the risk of cardioembolic events, even in patients with isolated, asymptomatic AMVT.^35,36

Conclusion

AMVT presents with a range of symptoms; patients may be asymptomatic or have severe complications such as thromboembolic events, heart failure, LVOT obstruction, and dangerous arrhythmias. It is often linked to other congenital cardiovascular anomalies. Echocardiography is crucial for diagnosing and monitoring AMVT, providing detailed insights into the lesion’s morphology, location, and relationship with surrounding structures as well as assessing LVOT hemodynamics and identifying coexisting malformations.

Footnotes

Acknowledgements

We would like to thank Lin Shi for his technical support and writing suggestions.

Author contributions

J.X. conceptualized and designed the study as well as drafted the initial manuscript. N.Z. and M.Z. were responsible for data collection and literature review. DN.G. and YF.W. critically reviewed and revised the manuscript and approved the final version for submission. All authors have read and approved the final manuscript. All authors have agreed to be accountable for all aspects of the work.

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors.

Declaration of conflicting interests

The authors declare no potential conflicts of interest with respect to the research, authorship, or publication of this article.

Ethical statement

The authors have de-identified all patient details in the Case report section, and this report has been granted approval for publication by the review committee.

Funding

The authors received no financial support for the research, authorship, or publication of this article.

ORCID iD

Jing Xu

References

Maclean

Culligan

Kane

DJ.

Subaortic stenosis due to accessory tissue on the mitral valve. The Journal of Thoracic and Cardiovascular Surgery 1963; 45: 382–388.

Meyer-Hetling

Alexi-Meskishvili

Dähnert

Critical subaortic stenosis in a newborn caused by accessory mitral valve tissue. Ann Thorac Surg 2000; 69: 1934–1937.

Gagnier

Kienle

Altman

; CARE Group*et al. The CARE guidelines: consensus-based clinical case reporting guideline development. Glob Adv Health Med 2013; 2: 38–43.

Cremer

Bechtelsheimer

Helpap

[Forms and development of subvalvular aortic stenosis]. Virchows Arch A Pathol Pathol Anat 1972; 355: 123–134.

Al-Atta

Khan

Sosin

Accessory mitral valve tissue causing features of left ventricular outflow tract obstruction-a case report and updated literature review. J Ayub Med Coll Abbottabad 2019; 31: 276–278.

Rovner

Thanigaraj

Perez

JE.

Accessory mitral valve in an adult population: the role of echocardiography in diagnosis and management. J Am Soc Echocardiogr 2005; 18: 494–498.

Manganaro

Zito

Khandheria

, et al. Accessory mitral valve tissue: an updated review of the literature. Eur Heart J Cardiovasc Imaging 2014; 15: 489–497.

Yuan

Shinfeld

Mishaly

, et al. Accessory mitral valve tissue: a case report and an updated review of literature. J Card Surg 2008; 23: 769–772.

Misumi

Nagao

Iwamoto

, et al. Acute multiple cerebral infarction in a patient with an accessory mitral valve. Intern Med 2017; 56: 153–155.

10.

Aonuma

Takehara

Saito

, et al. Adult accessory mitral valve with septal hypertrophy. Intern Med 2016; 55: 2515.

11.

Imai

Kawata

Okura

, et al. Accessory mitral valve tissue with mitral complex structural abnormality. J Echocardiogr 2015; 13: 76–78.

12.

Donmez

Seker

Icen

, et al. Incidental asymptomatic accessory mitral valve: a differential diagnosis for intracardiac mass. Acta Med Port 2014; 27: 779–782.

13.

Yetkin

Cuglan

Turhan

, et al. Accessory mitral valve tissue: anatomical and clinical perspectives. Cardiovasc Pathol 2021; 50: 107277.

14.

Yun

Park

Lee

, et al. Latent left ventricular outflow tract obstruction due to accessory mitral valve in a 12-year-old boy. Acta Cardiol Sin 2016; 32: 511–513.

15.

Prifti

Bonacchi

Bartolozzi

, et al. Postoperative outcome in patients with accessory mitral valve tissue. Med Sci Monit 2003; 9: RA126–RA133.

16.

Wang

, et al. A rare case of accessory mitral valve tissue causing left ventricular outflow tract obstruction associated with parachute mitral valve, ventricular septal defect, bicuspid aortic valve, unruptured aneurysm of aortic sinus: a case report. Eur Heart J Case Rep 2018; 2: yty082.

17.

Panduranga

Eapen

Al-Maskari

, et al. Accessory mitral valve tissue causing severe left ventricular outflow tract obstruction in a post-Senning patient with transposition of the great arteries. Heart Int 2011; 6: e6.

18.

Golias

Bitsis

Krikidis

, et al. Accessory mitral valve without subaortic obstruction of left ventricular outflow tract in a middle-aged male. BMJ Case Rep 2012; 2012: bcr2012006949.

19.

Uslu

Gorgulu

Yildirim

, et al. Accessory mitral valve tissue: report of two asymptomatic cases. Cardiology 2006; 105: 155–157.

20.

Yasui

Kado

Tokunaga

, et al. Trans-ventricular septal defect approach for resection of accessory mitral valve tissue. Ann Thorac Surg 1993; 55: 950–953.

21.

Alsaid

Cawley

Bauch

, et al. Hanging by a thread, severe mitral regurgitation due to accessory left atrial cord. Eur Heart J Cardiovasc Imaging 2016; 17: 943.

22.

Vlassak

Mumtaz

Pettersson

, et al. Accessory fibrous band causing anterior mitral valve leaflet restriction. Ann Thorac Surg 2002; 74: 592–593.

23.

Kızılkaya

Uysal

Bostan

ÖM

, et al. An unusual cause of aortic regurgitation: accessory mitral valve. Anatol J Cardiol 2018; 19: E3–E4.

24.

Galindo-Hayashi

Villarreal

Sanchez-Félix

ER.

Accessory mitral valve tissue: a differential diagnosis of an obstructive mass on the left ventricular outflow tract. Cardiol Young 2023; 33: 2661–2663.

25.

Kahyaoglu

Kalayci

Gecmen

, et al. A rare cause of retinal artery embolism: accessory mitral valve tissue. Echocardiography 2018; 35: 258–259.

26.

Garg

Agrawal

Sharma

GL.

Non-obstructive accessory mitral valve tissue in the left ventricular outflow tract with perimembranousventricular septal defect:a rare entity. J Cardiovasc Imaging 2020; 28: 158–160.

27.

Tamin

Dillon

Aizan

, et al. An accessory mitral valve leaflet causing left ventricular outflow tract obstruction and associated with severe aortic incompetence. Echocardiography 2012; 29: E34–E38.

28.

D'Onghia

Martin

Mancini

, et al. A late presentation of congenital cardiac anomaly: Accessory chordae from the left atrium causing severe mitral regurgitation. Echocardiography 2018; 35: 750–752.

29.

Gray

Mahon

NG.

Left ventricular outflow tract obstruction secondary to right atrial dilatation and accessory mitral valve tissue in a patient with Ebstein’s anomaly- case report. J Congenit Heart Dis 2019; 3: 7.

30.

Tenekecioğlu

Karabulut

Yılmaz

E-page original images. Accessory mitral valve associated with cerebrovascular thromboembolism. Anadolu Kardiyol Derg 2010; 10: E27–E28.

31.

Bär

Katus

Mereles

Accessory mitral valve as a potential source of cardioembolism. Int J Cardiol 2009; 131: e76–e77.

32.

Alizade

Çağan Efe

Kutlutürk

, et al. Occlusion of the retinal artery occlusion by undiagnosed accessory mitral valve tissue. Herz 2014; 39: 651–653.

33.

Azak

Aydın

Ecevit

, et al. Incidental detection of accessory mitral valve in adolescent with atrial septal defect: diagnosis with 3D transesophageal echocardiography and excision with transaortic method. Echocardiography 2022; 39: 851–854.

34.

Butler

Tjahjadi

Kang

, et al. Tri-leaflet mitral valve variant of hypertrophic obstructive cardiomyopathy: Comprehensive assessment with 3-D transesophageal echocardiography. Int J Cardiol 2015; 201: 549–551.

35.

Yetkin

Turhan

Atak

, et al. Accessory mitral valve tissue manifesting cerebrovascular thromboembolic event in a 34-year-old woman. Int J Cardiol 2003; 89: 309–311.

36.

Turhan

Yetkin

A potential source of cardioembolic cerebrovascular event: accessory mitral valve tissue. Int J Cardiol 2009; 133: e57.

Accessory mitral valve tissue causing left ventricular outflow tract obstruction associated with subaortic membrane and aortic sinus aneurysm: A case report and literature review

Abstract

Keywords

Introduction

Timeline

Case presentation

Discussion

Epidemiological data

Anatomical classification

Cardiac malformations and pathophysiology

Diagnosis

Treatment

Conclusion

Footnotes

Acknowledgements

Author contributions

Data availability statement

Declaration of conflicting interests

Ethical statement

Funding

ORCID iD

References